VEGFA and myeloid sarcoma: We could not demonstrate any significant correlation to age or a number of clinical or paraclinical parameters, such as EDSS, MSSS, disease duration or number of T2 MRI lesions, which is in agreement with a previous study [21].These results suggest that down regulation of VEGF-A mRNA expression in PBMC reflects an underlying disease mechanisms that operates specifically in progressive MS.